Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx.
Kalpakoff M, Hund S, Musser J, Roach C, Apostolaki A, Vilardo M, Peltz L, Watts B, LaPlaca C, Tabuena-Frolli S, DiMaio MA, Welcher R, Kulangara K.
Kalpakoff M, et al. Among authors: apostolaki a.
Appl Immunohistochem Mol Morphol. 2021 Oct 1;29(9):667-673. doi: 10.1097/PAI.0000000000000941.
Appl Immunohistochem Mol Morphol. 2021.
PMID: 33973887
Free PMC article.